| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.9M | — |
| Cost of Revenue | $7.1M | — |
| Gross Profit | $795K | — |
| R&D Expense | $99.1M | +39.0% |
| SG&A Expense | $69.2M | +142.6% |
| Operating Income | -$592.6M | -493.7% |
| Pre-tax Income | -$567.9M | -649.2% |
| Income Tax | $0 | — |
| Net Income | -$567.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.7M | -16.2% |
| Short-term Investments | $467.0M | -17.9% |
| Current Assets | $526.3M | -14.6% |
| Total Assets | $540.6M | -13.0% |
| Current Liabilities | $58.2M | +316.8% |
| Total Liabilities | $76.8M | +369.6% |
| Stockholders' Equity | $463.8M | -23.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$130.4M | -91.8% |
| Investing Cash Flow | $122.7M | +1275.4% |
| Financing Cash Flow | $331K | -47.3% |
| EPS (Basic) | -$2.11 | -502.9% |
| EPS (Diluted) | -$2.11 | -502.9% |